Literature DB >> 836809

A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

R G Di Scipio, M A Hermodson, S G Yates, E W Davie.   

Abstract

Human prothrombin, factor IX, and factor X have been idolated in high yield and characterized as the their amino-terminal sequence, molecular weight, amino acid composition, and migration in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. An additional human plasma protein, called protein S, has also been purified and its properties have been compared with those of prothrombin, factor IX, and factor X. Prothrombin (mol wt 72 000), factor IX (mol wt 57 000), and protein S (mol wt 69 000) are single-chain glycoproteins, while factor X (mol wt 59 000) is a glycoprotein composed of two polypeptide chains held together by a disulfide bond(s). The amino-terminal sequence of the light chain of human factor X is homologous with prothrombin, factor IX, and protein S. The heavy chain of human factor X is slightly larger than the heavy chain of bovine factor X and differs from bovine factor X in its amino-terminal sequence.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836809     DOI: 10.1021/bi00623a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  82 in total

1.  Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.

Authors:  T Imamura; S Tanase; T Hamamoto; J Potempa; J Travis
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

Authors:  S T Smiley; S N Boyer; M J Heeb; J H Griffin; M J Grusby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

4.  Isolation and characterization of a cDNA coding for human factor IX.

Authors:  K Kurachi; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.

Authors:  A K Sinha; A K Rao; J Willis; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.

Authors:  Raheleh Halabian; Mahdi Edalati Fathabad; Nasser Masroori; Amaneh Mohammadi Roushandeh; Sasan Saki; Nasser Amirizadeh; Ali Jahanian Najafabadi; Ahmad Gharehbaghian; Mehryar Habibi Roudkenar
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

7.  Protein S: a Multifunctional Anticoagulant.

Authors:  A'drianne Dorsey; Vijaya Satish Pilli; Howard Fried; Rinku Majumder
Journal:  Biomed Res Clin Pract       Date:  2017-11-20

8.  Phosphatidylserine and FVa regulate FXa structure.

Authors:  Kinshuk Raj Srivasatava; Rinku Majumder; William H Kane; Mary Ann Quinn-Allen; Barry R Lentz
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

9.  Human Protein Z.

Authors:  G J Broze; J P Miletich
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Physicochemical characterization of human S-protein and its function in the blood coagulation system.

Authors:  K T Preissner; R Wassmuth; G Müller-Berghaus
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.